📈 Stocks
Eli Lilly-Backed Scribe Therapeutics Soars 50% After Upsized IPO
(just now)
Eli Lilly-backed biotech Scribe Therapeutics jumps 50% after upsized IPO, signaling renewed biotech IPO momentum.